Literature DB >> 8943129

Infantile intestinal leiomyosarcoma: surgical resection (without adjuvant therapy) for cure.

B B Simpson1, E M Reynolds, S H Kim, W S Ferguson, F Graeme-Cook, D P Doody.   

Abstract

A 7-week-old boy presented with a 6-week history of failure to thrive, acute intestinal obstruction, and an apparently irreducible intussusception (noted on contrast enema). He underwent abdominal exploration, during which a cecal mass was identified and resected. The mass proved to be a leiomyosarcoma. Histologically, it was an intermediate-grade malignancy with a predicted 5-year survival rate of 16% to 23% based on data from the adult experience. Three years after resection and without having received adjuvant therapy, he is healthy and free of disease. A review of the literature showed that in infants these tumors are predominantly colonic, compared with the predilection for small intestinal lesions found in the older pediatric and adult populations. Infantile intestinal leiomyosarcomata are rare malignancies that do well if complete surgical excision of the disease can be accomplished. The histological prognostic indicators proposed for intestinal leiomyosarcomas in the adult population cannot be extrapolated to infants because when they occur in infants, they appear to be less aggressive, and these patients do well without adjuvant therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8943129     DOI: 10.1016/s0022-3468(96)90184-0

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

1.  Endoscopic features of intestinal smooth muscle tumor in a child with AIDS.

Authors:  Z L Molle; P Bornemann; N Desai; E Clarin; V Anderson; S S Rabinowitz
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Leiomyosarcoma of the mesentry, a rare mesentric tumour.

Authors:  Abbas K Sidhic; Mannalakkal Ranjith; Karat Parambil Abid Ali; Pappala Rahul Tej
Journal:  Int J Surg Case Rep       Date:  2014-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.